A Study of JNJ-61393215 in Healthy Japanese Male Participants

NCT04713930 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-61393215
DRUG: Placebo

Sponsor

Janssen Pharmaceutical K.K.